Entering Class: 2013
PhD Program: Neurosciences
Advisor: Gary Landreth, PhD & Bruce Lamb, PhD
Undergraduate Institution: University of California, Berkeley
Hometown: Union City, CA.
Research Interests: I am currently investigating the role of the triggering receptor expressed on myeloid cells-2 (TREM2) in mediating neuroinflammatory responses in the context of neurodegenerative disease.
About me: I was born in LA and grew up in the East Bay Area of northern California. After graduating from UC Berkeley in 2010, I conducted research at UC Berkeley and at the NINDS/NIH in Bethesda, MD. Outside of all things research and medicine, my interests include graduate level LGBT and underrepresented minority affairs and exploring Cleveland's great food, music, and cultural scenes. Please contact us if you have questions about community/diversity here at CWRU and in the greater Cleveland area.
Comment about the MSTP program: The CWRU MSTP is highly student driven and works seamlessly with the medical and graduate training programs. If you are interested in applying or are currently doing so, please feel free to contact any of us with questions.
Jay TR, Bemiller S, Neilson LE, Cheng PJ, Lamb BT. Chapter 6: Neuroinflammation and Neurodegenerative Diseases in Neurodegenerative Diseases: Unifying Principles. Cummings JL, Pillai J (Ed). Oxford, NY: Oxford University Press. 2016. NLM ID: 101669322
Carol T. Burds, Paul J. Cheng, Susan Wray. Chloride Accumulators NKCC1 and AE2 in Mouse GnRH Neurons: Implications for GABAA Mediated Excitation. PLOS One. June 25, 2015. DOI:10.1371/journal.pone.0131076
Jay TR, Miller CM, Cheng PJ, Graham LC, Bemiller S, Broihier ML, Xu G, Margevicius D, Karlo JC, Sousa GL, Cotleur AC, Butovsky O, Bekris L, Staugaitis SM, Leverenz JB, Pimplikar SW, Landreth GE, Howell GR, Ransohoff RM, Lamb BT. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. Journal of Experimental Medicine. Mar 9, 2015. DOI: 10.1084/jem.20142322. PubMed Central PMCID: PMC4354365
L. Damla Kotan, B. Ian Hutchins, Yusuf Ozkan, Fatma Demirel, Hudson Stoner, Paul J. Cheng, Ihsan Esen, Fatih Gurbuz, Y. Kenan Bicakci, Eda Mengen, Bilgin Yuksel, Susan Wray, A. Kemal Topaloglu. Mutations in FEZF1 Cause Kallmann Syndrome. The American Journal of Human Genetics. September 4, 2014. DOI: http://dx.doi.org/10.1016/j.ajhg.2014.08.006
Guy Bar-Klein, Luisa P. Cacheux, Lyn Kamintsky, Ofer Prager, Itai Weissberg, Karl Schoknecht, Paul Cheng, Soo Young Kim, Lydia Wood, Uwe Heinemann, Daniela Kaufer, Alon Friedman. Losartan prevents acquired epilepsy via TGF-β signaling suppression. Annals of Neurology. March 19, 2014. DOI: 10.1002/ana.24147
Edit your page here.